Miracle

Miracle, previously known as Miracle Health, operates from its headquarters at 2261 Market Street, San Francisco, CA. This healthcare company, with a team of three, falls under the drug discovery and delivery sub-industry. As a participant in the Y-Combinator W23 batch, Miracle focuses on integrating commonly used clinical trial platforms such as EDC, IRT, and study websites to offer real-time, automated insights through a unified dashboard. The company’s primary goal is to accelerate clinical trials and empower healthcare professionals in the biopharma sector by enabling quicker, data-driven decisions, thereby saving valuable time.

Miracle is committed to privacy and security, employing robust technical and organizational measures to protect personal information, and does not process sensitive personal data. It complies with relevant laws and regularly updates its privacy policy. The company uses cookies and similar tracking technologies for functionality and analytics, retaining personal information only as long as necessary for legitimate business purposes. Miracle provides mechanisms for users to exercise their privacy rights and does not knowingly collect data from or market to children under 18 years of age. For privacy-related inquiries, users can contact Miracle at info [at] miracleml [dot] com.